Senator Shaheen Pushes for Bipartisan Bill to Cap Insulin Cost at $35
TL/DR –
U.S. Senator Jeanne Shaheen hosted a roundtable discussion at Lamprey Health in Nashua to highlight the rising cost of insulin and advocate for her bipartisan INSULIN Act. The act would cap the monthly out-of-pocket cost of insulin at $35 for Americans with insurance and also create a pilot program to provide insulin at the same cost to Americans without insurance. According to a survey by the American Diabetes Association, 40% of respondents who rely on insulin report paying more than $150 per month for insulin, and 76% across all political parties support a $35 limit on cost-sharing for insulin.
Shaheen Advocates for Bipartisan Bill to Limit Insulin Costs at Health Care Roundtable
U.S. Senator Jeanne Shaheen (D-NH) put the spotlight on a bipartisan bill aiming to make insulin more affordable. She led a roundtable discussion at Lamprey Health in Nashua with healthcare leaders and diabetic individuals, discussing the soaring insulin prices and the need for the bipartisan INSULIN Act to pass.
The INSULIN Act aims at capping the monthly out-of-pocket cost for insulin at $35 for insured Americans and creating a pilot program to provide insulin at the same price to uninsured individuals. You can view the photos from the event here.
“Access to insulin is a life-or-death matter for the thousands of New Hampshire residents living with diabetes. They shouldn’t worry about affording this vital medication,” said Senator Shaheen. She reiterated the urgency to reduce insulin costs and vowed to tirelessly work to get her legislation across the finish line.
Senator Shaheen, co-chair of the U.S. Senate Diabetes Caucus, has been spearheading efforts to reduce healthcare costs. She has consistently demanded accountability from insulin manufacturers, insurers, and pharmacy benefit managers for escalating insulin prices and has championed support for patients and families battling diabetes. The INSULIN Act, passed by the U.S. Senate Health, Education, Labor, and Pensions (HELP) Committee on a wide bipartisan basis, is one step closer to Senate approval.
A poll from the American Diabetes Association revealed that 40% of insulin-dependent respondents spend over $150 per month on insulin, and 76% support a $35 cap on insulin cost sharing across political lines.
—
Read More Health & Wellness News ; US News